Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City
Author(s) -
Ashly E. Jordan,
Charles M. Cleland,
Katarzyna Wyka,
Bruce R. Schackman,
David C. Perlman,
Denis Nash
Publication year - 2019
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiz659
Subject(s) - incidence (geometry) , medicine , hepatitis c virus , seroconversion , cohort , hepatitis c , methadone , immunology , virus , anesthesia , physics , optics
Hepatitis C virus (HCV) incidence has increased in the worsening opioid epidemic. We examined the HCV preventive efficacy of medication-assisted treatment (MAT), and geographic variation in HCV community viral load (CVL) and its association with HCV incidence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom